Cargando…

Parental preferences for treatment: Preliminary report from a randomised comparison of treatment strategies in (early) juvenile idiopathic arthritis (BeSt for Kids trial)

Detalles Bibliográficos
Autores principales:	Muller, PCE Hissink, Brederije, I, Brinkman DMC, DMC, Allaart, CF, van Suijlekom-Smit, LWA, van Rossum, MAJ, ten Cate, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194540/ http://dx.doi.org/10.1186/1546-0096-9-S1-P184

Ejemplares similares

A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study
por: Hissink Muller, P. C. E., et al.
Publicado: (2017)

Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis
por: Albers, HM, et al.
Publicado: (2008)

PReS-FINAL-2160: Intestinal microbiome in polyarticular juvenile idiopathic arthritis: a pilot study
por: Hissink Muller, PC, et al.
Publicado: (2013)

When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis
por: Prince, FHM, et al.
Publicado: (2008)

Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?
por: Hissink Muller, Petra C. E., et al.
Publicado: (2018)

The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis
por: Albers, HM, et al.
Publicado: (2008)

Development of a web-based register for the Dutch national study on biologicals in juvenile idiopathic arthritis: http://www.abc-register.nl
por: Prince, FHM, et al.
Publicado: (2008)

Etanercept in juvenile idiopathic arthritis: Who will benefit?
por: Otten, MH, et al.
Publicado: (2011)

Association of the CD226 (DNAM-1) Gly307Ser polymorphism with juvenile idiopathic arthritis
por: Reinards, THCM, et al.
Publicado: (2011)

Association of the CCR5Δ32 variant with juvenile idiopathic arthritis in a meta-analysis
por: Reinards, THCM, et al.
Publicado: (2011)

No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis
por: Hissink Muller, P. C. E., et al.
Publicado: (2019)

Patterns of clinical joint inflammation in juvenile idiopathic arthritis
por: Heckert, Sascha L, et al.
Publicado: (2023)

Significant pain decrease in children with non-systemic Juvenile Idiopathic Arthritis treated to target: results over 24 months of follow up
por: Spekking, Katinka, et al.
Publicado: (2023)

PReS-FINAL-2145: MRP8/14 serum complexes as predictor of response to etanercept treatment in juvenile idiopathic arthritis
por: Anink, J, et al.
Publicado: (2013)

PReS-FINAL-2052: Costs of biologics in juvenile idiopathic arthritis: past, present and future
por: Prince, FH, et al.
Publicado: (2013)

Bone health assessment of patients with juvenile idiopathic arthritis: a comparison between DXA and bonexpert
por: Nusman, Charlotte M, et al.
Publicado: (2014)

A case report of clinical implications of a delayed antiretroviral therapy switch in a patient with multiple treatment interruptions
por: Kakubu, Mireille A Mpalang, et al.
Publicado: (2022)

Long term functional outcome and quality of life of patients with refractory juvenile idiopathic arthritis treated with etanercept: results of the dutch arthritis and biologicals in children register
por: Anink, Janneke, et al.
Publicado: (2014)

Automated determination of bone age and bone mineral density in patients with juvenile idiopathic arthritis: a feasibility study
por: Anink, Janneke, et al.
Publicado: (2014)

MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis
por: Anink, Janneke, et al.
Publicado: (2015)

PReS-FINAL-2146: Trends in prescription of biologics and outcomes of juvenile idiopathic arthritis; results of the Dutch national arthritis and biologicals in children register
por: Otten, MH, et al.
Publicado: (2013)

PReS-FINAL-2109: Genetic variations in patients with juvenile idiopathic arthritis and uveitis
por: Reinards, TH, et al.
Publicado: (2013)

PROTEÔMICA PLASMÁTICA QUANTITATIVA DE PACIENTES SOBREVIVENTES E NÃO SOBREVIVENTES DE COVID-19 INTERNADOS NO HOSPITAL REVELA POTENCIAIS BIOMARCADORES PROGNÓSTICOS E ALVOS TERAPÊUTICOS
por: Flora, DC, et al.
Publicado: (2022)

A miner with No left lung: Extensive pulmonary destruction in delayed effective Multi-Drug-Resistant Tuberculosis treatment
por: Katoto, Patrick D.M.C., et al.
Publicado: (2020)

Patient-reported joint count in juvenile idiopathic arthritis: the reliability of a mannequin format
por: Anink, Janneke, et al.
Publicado: (2014)

A comparison of the measurement properties of the Juvenile Arthritis Functional Assessment Scale with the childhood health assessment questionnaire in daily practice
por: Bekkering, W. Peter, et al.
Publicado: (2007)

MRI evaluation of clinical remission in juvenile idiopathic arthritis
por: van Veenendaal, M, et al.
Publicado: (2011)

MRP8/14 and neutrophil elastase for predicting treatment response and occurrence of flare in patients with juvenile idiopathic arthritis
por: Barendregt, Anouk M, et al.
Publicado: (2020)

Decreased Fixation Stability of the Preferred Retinal Location in Juvenile Macular Degeneration
por: Bethlehem, Richard A. I., et al.
Publicado: (2014)

Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis
por: Katoto, Patrick DMC., et al.
Publicado: (2023)

Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences
por: Brinkman, William B, et al.
Publicado: (2011)

Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response
por: Lerkvaleekul, Butsabong, et al.
Publicado: (2021)

Prevalence and Impact of HIV Infections in Patients with Rheumatic Heart Disease: A Systematic Review and Meta-Analysis
por: Lumngwena, Evelyn N., et al.
Publicado: (2023)

Development of consensus best treatment plans for new-onset systemic juvenile idiopathic arthritis
por: Morgan DeWitt, Esi M, et al.
Publicado: (2012)

Dystrophie maculaire juvénile de Best
por: Abdelkhalek, Ryme, et al.
Publicado: (2014)

Reported incidence and treatment of dermatophytosis in children in general practice: a comparison between 1987 and 2001
por: Mohammedamin, R. S. A., et al.
Publicado: (2007)

Physician preferences in diagnostics and treatment of juvenile osteochondritis dissecans are diverse across the knee, ankle and elbow: an ESSKA survey
por: Kemmeren, Laura A. M., et al.
Publicado: (2023)

Treatment of Allergic Rhinitis Is Associated with Improved Attention Performance in Children: The Allergic Rhinitis Cohort Study for Kids (ARCO-Kids)
por: Kim, Dong-Kyu, et al.
Publicado: (2014)

Predictors of Changes in Sleep Duration in Dutch Primary Schoolchildren: the ChecKid Study
por: Komrij, Nina L., et al.
Publicado: (2020)

Adolescent and caregiver preferences for juvenile idiopathic arthritis treatment: a discrete-choice experiment
por: McErlane, Flora, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_erugri2gha411m3k7q9tt7k429